Showing results (61-70 of 123) with videos related to
Sort By:
Pageof 13
Annals of Surgical Oncology|April 23, 2020
CA19-9 Change During Neoadjuvant Therapy May Guide the Need for Additional Adjuvant Therapy Following Resected Pancreatic CancerHao Liu, Mazen S Zenati, Caroline J Rieser, et al.Journal of Surgical Oncology|April 24, 2021
Predictors of early recurrence following neoadjuvant chemotherapy and surgical resection for localized pancreatic adenocarcinomaSowmya Narayanan, Samer AlMasri, Mazen Zenati, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 9, 2016
Primary Tumor Resection Following Favorable Response to Systemic Chemotherapy in Stage IV Pancreatic Adenocarcinoma with Synchronous Metastases: a Bi-institutional AnalysisG Paul Wright, Katherine E Poruk, Mazen S Zenati, et al.Cancer Chemotherapy and Pharmacology|March 10, 2018
A phase I trial of escalating doses of cixutumumab (IMC-A12) and sorafenib in the treatment of advanced hepatocellular carcinomaAnthony B El-Khoueiry, Robert O'Donnell, Thomas J Semrad, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 24, 2015
The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesotheliomaAatur D Singhi, Alyssa M Krasinskas, Haroon A Choudry, et al.Journal of the National Comprehensive Cancer Network : JNCCN|December 27, 2023
Impact of Recombinant Granulocyte Colony-Stimulating Factor During Neoadjuvant Therapy on Outcomes of Resected Pancreatic CancerPranav Murthy, Mazen S Zenati, Samer S AlMasri, et al.HPB : the Official Journal of the International Hepato Pancreato Biliary Association|January 7, 2023
The use of angiotensin system inhibitors correlates with longer survival in resected pancreatic adenocarcinoma patientsHao Liu, Ibrahim Nassour, Steven Lebowitz, et al.Gastroenterology Research and Practice|July 4, 2018
Overweight or Obese Individuals at Eighteen Years of Age Develop Pancreatic Adenocarcinoma at a Significantly Earlier AgeDavid T Chao, Nilesh H Shah, Herbert J Zeh, et al.Cancers|April 13, 2024
Results of a Randomized, Double-Blind, Placebo-Controlled, Phase 1b/2 Trial of Nabpaclitaxel + Gemcitabine ± Olaratumab in Treatment-Naïve Participants with Metastatic Pancreatic CancerFaithlore P Gardner, Zev A Wainberg, Christos Fountzilas, et al.Radiation Oncology (London, England)|November 2, 2013
Pathologic response with neoadjuvant chemotherapy and stereotactic body radiotherapy for borderline resectable and locally-advanced pancreatic cancerMalolan S Rajagopalan, Dwight E Heron, Rodney E Wegner, et al.Pageof 13